FDA Adverse Event Injury Summary report: N

NOVASURE IMPEDANCE CONTROLLED EA SYSTEM

MDR report key: 1972214 · Received January 19, 2011

Report

Report Number
1222780-2011-00012
Event Type
Injury
Date Received
January 19, 2011
Date of Event
December 20, 2010
Report Date
December 20, 2010
Manufacturer
HOLOGIC
Product Code
MNB
PMA / PMN Number
P010013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LOT AND SERIAL NUMBER OF THE DISPOSABLE DEVICE NOT PROVIDED BY THE COMPLAINANT; THEREFORE, THE EXPIRATION DATE OF THE DISPOSABLE NOVASURE DEVICE IS NOT KNOWN. THE DISPOSABLE DEVICE HAS NOT YET BEEN RETURNED THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE HAS NOT YET BEEN COMPLETED. THE RADIO FREQUENCY CONTROLLER IS NOT BEING RETURNED THEREFORE, A FAILURE ANALYSIS OF THE CONTROLLER CAN NOT BE COMPLETED. LOT NUMBER OF THE DISPOSABLE DEVICE NOT PROVIDED BY THE COMPLAINANT; THEREFORE, THE MANUFACTURE DATE OF THE DEVICE IS NOT KNOWN. MANUFACTURE DATE OF THE RADIO FREQUENCY CONTROLLER IS (B)(6) 2009. DEVICE HISTORY RECORD (DHR) REVIEW COULD NOT BE CONDUCTED FOR THE DISPOSABLE DEVICE AS A LOT NUMBER WAS NOT PROVIDED BY THE COMPLAINANT. DEVICE HISTORY RECORD (DHR) REVIEW WAS CONDUCTED FOR THE RADIO FREQUENCY CONTROLLER (SERIAL# (B)(4)). THE DEVICE WAS RELEASED MEETING ALL SPECIFICATIONS. NO RELATIONSHIP CAN BE ESTABLISHED BETWEEN DHR AND CURRENT COMPLAINT. IF ADDITIONAL RELEVANT INFO OR THE DEVICE IS RECEIVED, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

FOLLOWING A "SUCTION D&C [DILATATION AND CURETTAGE]" AND A NOVASURE ENDOMETRIAL ABLATION THE PHYSICIAN DID A LAPAROSCOPY FOR THE PURPOSE OF PERFORMING A TUBAL STERILIZATION. SHE NOTED "A BLANCHED AREA ON THE POSTERIOR ASPECT OF THE UTERINE FUNDUS WITHOUT EVIDENCE OF PERFORATION. ADDITIONALLY, SHE SAW A 1CM AREA OF BLANCHING ON THE RECTO-SIGMOID COLON". TREATMENT INCLUDED "PLACING A JACKSON PRATT (JP) DRAIN THROUGH ONE OF THE LAPAROSCOPIC TROCAR SITES FOR ONE WEEK", ADMINISTRATION OF FLAGYL (METRONIDAZOLE), DOSE UNK, AND A LIQUID DIET. THE PT WAS DISCHARGED HOME. ON (B)(6) 2011, THE PHYSICIAN REPORTED "THE PT IS DOING GREAT, NO PROBLEMS, NO ISSUES OR CONCERNS AT ALL".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NOVASURE IMPEDANCE CONTROLLED EA SYSTEM MNB HOLOGIC NS2000 UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention RADIO FREQUENCY CONTROLLER| SERIAL NUMBER (B)(4)